Overview

Safe Implementation of Thrombolysis in Stroke - Monitoring Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety and efficacy of intravenous alteplase within 3 hours of symptom onset in acute ischemic stroke patients
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tissue Plasminogen Activator